Genetically modified T cell therapy shown to be safe, lasting in decade-long study of HIV patients
HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Tr ...
HIV & AIDS
May 02, 2012 |
5 / 5 (1) |
0
Real-time monitoring of cellular signalling events
(Medical Xpress) -- Phosphorylation is one of the most important and ubiquitous cell regulatory events. EU-funded researchers assessed the dynamic events of intracellular phosphorylation in two model systems with important ...
Cancer
May 02, 2012 |
not rated yet |
0
Team announces breakthrough for degenerative vision disorder
A research team, led by John Guy, M.D., professor of ophthalmology at Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine, has pioneered a novel technological treatment for Leber Hereditary Optic ...
Ophthalmology
Apr 23, 2012 |
not rated yet |
0
Potential gene therapy for patients with rare disease
Australian scientists have discovered that a biological phenomenon known as ‘somatic reversion’, when an abnormal gene spontaneously becomes normal again, explains why some patients with a rare genetic ...
Medical research
Apr 12, 2012 |
5 / 5 (2) |
0
Asthma: A vaccination that works using intramuscular injection
Asthma is a chronic inflammatory and respiratory disease caused by an abnormal reactivity to allergens in the environment. Of the several avenues of exploration that are currently being developed, vaccination appears to be ...
Inflammatory disorders
Apr 04, 2012 |
5 / 5 (3) |
0
The path to personalized cancer treatment
In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 Mar ...
Cancer
Mar 28, 2012 |
5 / 5 (2) |
0
|
New gene therapy approach developed for red blood cell disorders
A team of researchers led by scientists at Weill Cornell Medical College has designed what appears to be a powerful gene therapy strategy that can treat both beta-thalassemia disease and sickle cell anemia. They have also ...
Genetics
Mar 27, 2012 |
5 / 5 (5) |
0
|
Largest gene therapy trial for cystic fibrosis begins
(Medical Xpress) -- British scientists are to carry out the largest trial anywhere in the world of a gene therapy for cystic fibrosis.
Medical research
Mar 16, 2012 |
5 / 5 (2) |
0
Combination treatment in mice shows promise for fatal neurological disorder in kids
Infants with Batten disease, a rare but fatal neurological disorder, appear healthy at birth. But within a few short years, the illness takes a heavy toll, leaving children blind, speechless and paralyzed. ...
Neuroscience
Mar 15, 2012 |
5 / 5 (2) |
0
|
Scientists develop gene therapy approach to grow blood vessels in ischemic limbs
A new research discovery by a team of Stanford and European scientists offers hope that people with atherosclerotic disease may one day be able to avoid limb amputation related to ischemia. A new research report appearing ...
Genetics
Mar 06, 2012 |
5 / 5 (2) |
0
|
Neurons change shape after gene therapy
(Medical Xpress) -- Gene therapy not only helps injured brain cells to live longer and regenerate, but also changes the shape of the cells, according to researchers The University of Western Australia.
Genetics
Feb 16, 2012 |
5 / 5 (3) |
1
Gene therapy for epilepsy could stop seizures
(Medical Xpress) -- Sparking production of a hormone in the brain that people with epilepsy often lack could prevent debilitating seizures, University of Florida researchers have discovered.
Neuroscience
Feb 15, 2012 |
4.3 / 5 (6) |
0
|
Gene therapy for inherited blindness succeeds in patients' other eye
Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye. After receiving the same treatment in their ...
Medical research
Feb 08, 2012 |
5 / 5 (2) |
0
|
Defects in the packaging of DNA in malignant brain tumors
Glioblastomas grow extremely aggressively into healthy brain tissue and, moreover, are highly resistant to radiation therapy and chemotherapy. Therefore, they are regarded as the most malignant type of brain tumor. Currently ...
Cancer
Jan 30, 2012 |
not rated yet |
0
|
Gene therapy is a 'disruptive science' ready for commercial development
The time for commercial development of gene therapy has come. Patients with diseases treatable and curable with gene therapy deserve access to the technology, which has demonstrated both its effectiveness ...
Genetics
Jan 24, 2012 |
5 / 5 (3) |
1
